Logo

Lung Diseases Cochrane Pediatric Emergency Medicine Reviews

Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews

Cochrane Systematic Review: Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis

Cochrane Systematic Review: Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis

Visit

Lands LC, Stanojevic S

Lands LC, Stanojevic S

OBJECTIVES: To assess the effectiveness of treatment with NSAIDs in CF.

OBJECTIVES: To assess the effectiveness of treatment with NSAIDs in CF.

Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis

Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis

Visit

Hurley MN, Forrester DL, Smyth AR

Hurley MN, Forrester DL, Smyth AR

OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.

OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.

Cochrane Systematic Review: Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis

Cochrane Systematic Review: Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis

Visit

Lands LC, Stanojevic S

Lands LC, Stanojevic S

OBJECTIVES: To assess the effectiveness of treatment with NSAIDs in CF.

OBJECTIVES: To assess the effectiveness of treatment with NSAIDs in CF.

Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis

Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis

Visit

Hurley MN, Forrester DL, Smyth AR

Hurley MN, Forrester DL, Smyth AR

OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.

OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.